Browse Category

Market News News 7 January 2026 - 8 January 2026

Seagate stock (STX) slides after CES-fueled rally cools; earnings date ahead

Seagate stock (STX) slides after CES-fueled rally cools; earnings date ahead

NEW YORK, Jan 7, 2026, 18:50 EST — After-hours Seagate Technology Holdings plc (STX) shares fell about 6.7% to $308.26 in after-hours trading on Wednesday, trimming a sharp run that had pushed the data-storage maker to fresh highs earlier in the week. The stock traded between $299.04 and $330.42 during the session. The pullback tracked a wider cooling in memory…
Fermi Inc stock slides 10% on fresh class-action filing headlines, with Evercore conference next

Fermi Inc stock slides 10% on fresh class-action filing headlines, with Evercore conference next

New York, January 7, 2026, 13:24 (EST) — Regular session Shares of Fermi Inc (FRMI.O) slid on Wednesday, last down $1.01, or about 10.6%, at $8.50. The stock hit an intraday low of $8.37 and had traded about 5.6 million shares. The move came as plaintiffs’ firms pushed fresh notices around a proposed securities class action lawsuit, reopening questions about…
TORM (TRMD) stock jumps as Oaktree drops below one-third — what changes next

TORM (TRMD) stock jumps as Oaktree drops below one-third — what changes next

NEW YORK, Jan 7, 2026, 12:46 EST — Regular session TORM plc shares jumped 6.7% to $21.85 in midday U.S. trade on Wednesday. The product tanker owner said Oaktree Capital Management and its affiliates have fallen below a one-third ownership threshold, triggering a governance reset. Nasdaq That matters now because the “threshold date” strips out a set of limits written…
7 January 2026
Boeing stock edges higher on Alaska’s 110-jet order, but MAX 10 approval is the next hurdle

Boeing stock edges higher on Alaska’s 110-jet order, but MAX 10 approval is the next hurdle

New York, Jan 7, 2026, 12:40 EST — Regular session Boeing stock rose modestly on Wednesday after Alaska Air Group placed its biggest-ever aircraft order with the planemaker. Shares were up 0.4% at $230.78, after climbing nearly 2% earlier in the session. Reuters The order lands as Boeing tries to lift jet output under close U.S. regulatory scrutiny. The Federal…
DHT Holdings stock jumps as tanker shares rally on Venezuela oil shake-up

DHT Holdings stock jumps as tanker shares rally on Venezuela oil shake-up

NEW YORK, Jan 7, 2026, 11:52 (EST) — Regular session Shares of DHT Holdings, Inc. rose 6.6% to $12.81 on Wednesday, extending a broad rally in U.S.-listed tanker stocks during the regular session. Frontline gained about 8%, Teekay Tankers added about 9%, Scorpio Tankers rose about 5% and Nordic American Tankers climbed about 6.7%. The move matters because DHT is…
Structure Therapeutics stock climbs on $100 million Roche-Genentech patent deal; what investors watch next

Structure Therapeutics stock climbs on $100 million Roche-Genentech patent deal; what investors watch next

New York, Jan 7, 2026, 11:50 a.m. EST — Regular session Shares of Structure Therapeutics Inc rose 5.6% to $66.75 in late-morning trade on Wednesday, recovering from early swings as investors sized up a newly disclosed patent license deal tied to Roche and Genentech’s oral obesity drug effort. The agreement matters because it puts near-term cash on the table for…
Frontline (FRO) stock jumps as Venezuela tanker seizures stir oil-shipping bets

Frontline (FRO) stock jumps as Venezuela tanker seizures stir oil-shipping bets

New York, Jan 7, 2026, 11:12 EST — Regular session Frontline plc (FRO.N) shares rose about 7.7% to $23.27 by 11:12 a.m. EST on Wednesday, after swinging between $21.69 and $23.48 in early trading. The move came as traders leaned into crude-tanker names after the United States said it had seized a Venezuela-linked tanker that had been reflagged under Russia,…
Crinetics (CRNX) shares jump as $350 million stock sale clears and early PALSONIFY revenue hits

Crinetics (CRNX) shares jump as $350 million stock sale clears and early PALSONIFY revenue hits

New York, Jan 7, 2026, 11:04 EST — Regular session Shares of Crinetics Pharmaceuticals rose about 16% to $53.40 on Wednesday, after the biotech priced a $350 million stock offering and detailed early U.S. launch metrics for its newly approved acromegaly drug. Crinetics said it generated preliminary, unaudited net product revenue of more than $5 million from PALSONIFY in the…
Gold stocks slide as gold price pulls back; Newmont, GDX drop with U.S. payrolls ahead

Gold stocks slide as gold price pulls back; Newmont, GDX drop with U.S. payrolls ahead

New York, Jan 7, 2026, 10:10 EST — Regular session Gold stocks fell on Wednesday as bullion prices slipped, with Newmont down 3.1% at $105.80 and the VanEck Gold Miners ETF off 3.7% at $88.73. SPDR Gold Shares, a major gold-backed fund, fell 1.1% to $408.81, while Agnico Eagle slid 2.9% and Gold Fields dropped 5.9%. Spot gold — the…
Ondas (ONDS) stock slides in premarket as Needham conference and share-sale filings hit the tape

Ondas (ONDS) stock slides in premarket as Needham conference and share-sale filings hit the tape

New York, January 7, 2026, 08:35 EST — Premarket Ondas Holdings Inc shares were down 3.5% at $12.39 in premarket trade on Wednesday after the company said Chief Executive Eric Brock will take part in a fireside chat at the Needham Growth Conference next week. The stock closed Tuesday at $12.84. StockAnalysis The timing matters because Ondas has stacked investor-facing…
Oil stocks, USO ETF slide in premarket as Trump Venezuela crude plan stirs supply fears

Oil stocks, USO ETF slide in premarket as Trump Venezuela crude plan stirs supply fears

New York, January 7, 2026, 07:34 EST — Premarket U.S. oil stocks and oil-linked exchange-traded funds slipped in premarket trading on Wednesday as crude prices fell after President Donald Trump said the United States struck a deal to import up to $2 billion worth of Venezuelan crude. Brent futures were at $60.59 a barrel and U.S. West Texas Intermediate (WTI)…
1 10 11 12 13 14 64

Stock Market Today

  • DaVita Stock Holds Potential Despite Mixed Q3 Results and Market Challenges
    January 19, 2026, 2:23 PM EST. DaVita Inc. (DVA), a global kidney care provider, faces a 24.9% stock decline year-to-date versus the industry's 11.2% growth and S&P 500's 12.9% rise. Its patient-centric business model integrating kidney care platforms shows promise, supporting better treatment options and value-based care earnings. DaVita's international expansion across key emerging and developed markets, with acquisitions of dialysis centers in Brazil, China, and Europe, aims to boost overseas revenue. The company serves roughly 293,200 patients worldwide and projects 12.6% growth over five years. Despite mixed third-quarter 2025 performance and concerns over dependence on commercial payers, management remains optimistic about sustaining growth and enhancing care delivery.
Go toTop